# Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)

> **NCT07553728** · — · NOT_YET_RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Infertility

## Interventions

- **OTHER:** NA，Observational study

## Key facts

- **NCT ID:** NCT07553728
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2029-08-04
- **Final completion:** 2029-12-16
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553728, "Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07553728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*